Apalutamide is an androgen receptor inhibitor indicated for the treatment of patients with metastatic castration-sensitive ...

The company got the nod to manufacture and market apalutamide tablets, 60 mg, the generic equivalent of Erleada tablets, 60 ...

Zydus Lifesciences rose 1.67% to Rs 897.25 after the firm said that the US Food and Drug Administration (USFDA) conducted a surveillance inspection at the company's Active Pharmaceutical Ingredient ...

The NSE Nifty 50 ended 0.33% lower at 22,397.20, while the BSE Sensex closed 0.27% down at 73,828.9 on Thursday.

Shares of firms like TCS, Tata Motors, Infosys, IndusInd Bank, IRFC, Power Grid, and others will be in focus on Monday's ...

Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration to manufacture ...

Keep an eye on stocks like Infosys , Wipro, IndusInd Bank and more as the market resumes trading after Holi. Explore key market updates and company actions today!

Inspection occurred from March 10, 2025 to March 14, 2025 and ended with no observations with full compliance.

The surveillance inspection, conducted from March 10 to March 14, 2025, concluded without any observations. On Thursday ...

Ahmedabad: Zydus Lifesciences has announced that the US Food and Drug Administration (USFDA) has concluded a surveillance ...

Zydus Lifesciences has announced that the US Food and Drug Administration (USFDA) conducted a surveillance inspection at the company's Active Pharmaceutical Ingredient (API) Unit 1, located in ...